Showcasing the next generation of gene writing tools to cure diseases for Integra Therapeutics

The lead technology is FiCAT, a best-in-class platform geared towards resolving the current limitations on gene writing: size, precision, and stability. FiCAT combines the precision of CRISPR-Cas and the transfer efficiency of an engineered piggyBac transposase protein with the capability to deliver small and large payloads.

The Goal

"To manifest the advanced therapies in genetic and oncological diseases."

Challenge

Our Approach

Results

Outstanding animation feature: accurately showing the key message

Integra Therapeutic has engineered a machine that can integrate genes of any size into the genome in an efficient and precise manner. The animation shows in detail how the piggyBac transposase inside the cell provides efficient and accurate insertion of the therapeutic gene of almost any size into the genome.

 

Taking into account the vision of the client in combination with professional recommendations from our side - brings the best result

We take into consideration all the wishes and requirements of the client, and at the same time, our team always provides highly qualified advice on visual implementation and compliance with the correctness of the picture from a medical point of view.

The healthy cell is demonstrated with a nucleus and chromosomes to show how the FiCAT unlocks the potential of programmable transposition gene writing modality.

 

Results

3D Light animation, demonstrating the basic principle of the leading FiCAT technology and what problems it is aimed at solving.

 

"I have really enjoyed the creative process of generating this video with the nanobot medical team; they understood our goal and were willing to accommodate our needs. In addition, it was a blast working with such a high-performance team of women in STEM and design!"